Atoms-to-Animals: Structural Genomics of Immunity

原子到动物:免疫结构基因组学

基本信息

  • 批准号:
    8514011
  • 负责人:
  • 金额:
    $ 105.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Immune Function Network (IFN), a consortium of immunologists, geneticists, computational biochemists, and high throughput structural biologists, is committed to the coordinated structural, in vitro biochemical and in vivo functional analyses of the secreted molecules and ectodomains of cell surface molecules that control adaptive and innate immunity. These molecules are validated targets for immune-based therapies to treat a wide range of autoimmune diseases, infectious diseases and cancers, and are indeed therapeutics in their own right. The IFN, subscribes to a series of underlying principles: 1) target selection supports hypothesis-driven structural biology by identifying unique primary amino acid sequence signatures that predict unique structural features, which are in turn responsible for unique biological function; 2) the high resolution structures of these molecules are exceptionally revealing as they inform on oligomeric state, valency, specificity and general architectural features, all of which are fundamental mechanistic contributors to immune function; 3) these structures can be readily exploited by biochemical and computational approaches to guide the generation of molecules with specifically altered biochemical and biophysical properties; 4) these "surgically-defined" mutants represent novel reagents that will lead to new mechanistic insights in in vitro cell-based assays and in vivo animal models of disease; 5) the molecules predicted to be most informative will guide the generation of knock-in mouse models to provide in vivo structure-function relationships for innate and adaptive immunity. This "Atoms-to-Animals" approach represents the next step in the evolution of Structural Biology as it maximally leverages structural information and provides a comprehensive and powerful paradigm for the study of normal, pathological, and therapeutic immune responses.
描述(由申请人提供):免疫功能网络(IFN)是一个由免疫学家、遗传学家、计算生物化学家和高通量结构生物学家组成的联盟,致力于对控制适应性和先天性免疫的细胞表面分子的分泌分子和胞外域进行协调的结构、体外生物化学和体内功能分析。这些分子是经过验证的免疫疗法的靶点,可治疗多种自身免疫性疾病、传染病和癌症,而且它们本身确实是治疗方法。IFN遵循一系列基本原则:1)靶选择通过鉴定预测独特结构特征的独特一级氨基酸序列特征来支持假说驱动的结构生物学,所述独特一级氨基酸序列特征进而负责独特的生物学功能; 2)这些分子的高分辨率结构特别具有启示性,因为它们提供了寡聚状态、化合价、特异性和一般结构特征,所有这些都是免疫功能的基本机制贡献者; 3)这些结构可以很容易地被生物化学和计算利用, 4)这些“化学定义的”突变体代表了新的试剂,其将导致在体外基于细胞的测定和体内疾病动物模型中的新的机理见解; 5)被预测为最具信息性的分子将指导基因敲入小鼠模型的产生以提供体内结构-先天免疫和适应性免疫的功能关系。这种“原子到动物”的方法代表了结构生物学进化的下一步,因为它最大限度地利用了结构信息,并为正常,病理和治疗性免疫反应的研究提供了全面而强大的范例。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arturo Casadevall其他文献

Arturo Casadevall的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arturo Casadevall', 18)}}的其他基金

The biology of Cryptococcus neoformans melanization
新型隐球菌黑化的生物学
  • 批准号:
    10660435
  • 财政年份:
    2023
  • 资助金额:
    $ 105.59万
  • 项目类别:
Exploiting antibody catalysis for treating Cryptococcosis
利用抗体催化治疗隐球菌病
  • 批准号:
    10326944
  • 财政年份:
    2021
  • 资助金额:
    $ 105.59万
  • 项目类别:
Exploiting antibody catalysis for treating Cryptococcosis
利用抗体催化治疗隐球菌病
  • 批准号:
    10410573
  • 财政年份:
    2021
  • 资助金额:
    $ 105.59万
  • 项目类别:
Exploiting antibody catalysis for treating Cryptococcosis
利用抗体催化治疗隐球菌病
  • 批准号:
    10609085
  • 财政年份:
    2021
  • 资助金额:
    $ 105.59万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement
用于预防和治疗隐球菌病的结合疫苗 - COVID-19 修订补充资料
  • 批准号:
    10265635
  • 财政年份:
    2020
  • 资助金额:
    $ 105.59万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis
用于预防和治疗隐球菌病的结合疫苗
  • 批准号:
    10339408
  • 财政年份:
    2020
  • 资助金额:
    $ 105.59万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis
用于预防和治疗隐球菌病的结合疫苗
  • 批准号:
    10582699
  • 财政年份:
    2020
  • 资助金额:
    $ 105.59万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis
用于预防和治疗隐球菌病的结合疫苗
  • 批准号:
    10117191
  • 财政年份:
    2020
  • 资助金额:
    $ 105.59万
  • 项目类别:
Biological and Clinical Impact of Cryptococcal Extralcellular Vesicles
隐球菌细胞外囊泡的生物学和临床影响
  • 批准号:
    8958486
  • 财政年份:
    2014
  • 资助金额:
    $ 105.59万
  • 项目类别:
Development of new passive immunization strategies for anthrax
开发新的炭疽被动免疫策略
  • 批准号:
    8230240
  • 财政年份:
    2011
  • 资助金额:
    $ 105.59万
  • 项目类别:

相似海外基金

Investigating how TRAF1 Controls Inflammasome Activation in Animal Disease Models of Inflammatory Arthritis and Peritonitis
研究 TRAF1 如何控制炎症性关节炎和腹膜炎动物疾病模型中的炎症小体激活
  • 批准号:
    449429
  • 财政年份:
    2020
  • 资助金额:
    $ 105.59万
  • 项目类别:
    Studentship Programs
Establishment of animal disease models for intractable pediatric diseases due to defects of RNA metabolism and development of new therapeutics
RNA代谢缺陷引起的儿科疑难疾病动物模型的建立及新疗法的开发
  • 批准号:
    20H03644
  • 财政年份:
    2020
  • 资助金额:
    $ 105.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of type 2 diabetes susceptibility genes using animal disease models
利用动物疾病模型对2型糖尿病易感基因进行功能分析
  • 批准号:
    18K08466
  • 财政年份:
    2018
  • 资助金额:
    $ 105.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cell therapy of adipocytes derived from human iPS cells using cellcontainers and animal disease models
使用细胞容器和动物疾病模型对源自人类 iPS 细胞的脂肪细胞进行细胞治疗
  • 批准号:
    24659444
  • 财政年份:
    2012
  • 资助金额:
    $ 105.59万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of genes involved in the pathogenesis of the arthritis using animal disease models..
使用动物疾病模型分析涉及关节炎发病机制的基因。
  • 批准号:
    17500284
  • 财政年份:
    2005
  • 资助金额:
    $ 105.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ESTABLISHMENT OF THE DEVELOPING AND SUPPLING SYSTEMS FOR NEW ANIMAL,DISEASE MODELS FROM SUBSPECIES OF THE MOUSE
小鼠亚种新动物、疾病模型的开发和供应体系的建立
  • 批准号:
    07556128
  • 财政年份:
    1995
  • 资助金额:
    $ 105.59万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了